Avgemsi 83831-0123
Generic: Gemcitabine
Product NDC
83831-0123- Manufacturer
- Avyxa Pharma, Llc
- Dosage Form
- Injection, Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- August 3, 2025
- Listing Expires
- December 31, 2026
- Application
- NDA219920
Need to source Avgemsi? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Gemcitabine Hydrochloride | 38 mg/mL |
Drug Class
Nucleic Acid Synthesis Inhibitors [MoA]Nucleoside Metabolic Inhibitor [EPC]
Packaging Options(1)
1 VIAL, MULTI-DOSE in 1 CARTON (83831-123-01) / 26.3 mL in 1 VIAL, MULTI-DOSE